189 related articles for article (PubMed ID: 8755738)
1. Active-site structure analysis of recombinant human inducible nitric oxide synthase using imidazole.
Chabin RM; McCauley E; Calaycay JR; Kelly TM; MacNaul KL; Wolfe GC; Hutchinson NI; Madhusudanaraju S; Schmidt JA; Kozarich JW; Wong KK
Biochemistry; 1996 Jul; 35(29):9567-75. PubMed ID: 8755738
[TBL] [Abstract][Full Text] [Related]
2. Interferon-gamma-inducible murine macrophage nitric oxide synthase: studies on the mechanism of inhibition by imidazole agents.
Wolff DJ; Gribin BJ
Arch Biochem Biophys; 1994 Jun; 311(2):293-9. PubMed ID: 7515612
[TBL] [Abstract][Full Text] [Related]
3. The natural product noformycin is an inhibitor of inducible-nitric oxide synthase.
Green BG; Chabin R; Grant SK
Biochem Biophys Res Commun; 1996 Aug; 225(2):621-6. PubMed ID: 8753809
[TBL] [Abstract][Full Text] [Related]
4. Formation of nitric oxide synthase-iron(II) nitrosoalkane complexes: severe restriction of access to the iron(II) site in the presence of tetrahydrobiopterin.
Renodon A; Boucher JL; Wu C; Gachhui R; Sari MA; Mansuy D; Stuehr D
Biochemistry; 1998 May; 37(18):6367-74. PubMed ID: 9572852
[TBL] [Abstract][Full Text] [Related]
5. N-nitro-L-arginine and N-monomethyl-L-arginine exhibit a different pattern of inactivation toward the three nitric oxide synthases.
Reif DW; McCreedy SA
Arch Biochem Biophys; 1995 Jun; 320(1):170-6. PubMed ID: 7540822
[TBL] [Abstract][Full Text] [Related]
6. Thiols and neuronal nitric oxide synthase: complex formation, competitive inhibition, and enzyme stabilization.
Gorren AC; Schrammel A; Schmidt K; Mayer B
Biochemistry; 1997 Apr; 36(14):4360-6. PubMed ID: 9100033
[TBL] [Abstract][Full Text] [Related]
7. Allosteric regulation of neuronal nitric oxide synthase by tetrahydrobiopterin and suppression of auto-damaging superoxide.
Kotsonis P; Fröhlich LG; Shutenko ZV; Horejsi R; Pfleiderer W; Schmidt HH
Biochem J; 2000 Mar; 346 Pt 3(Pt 3):767-76. PubMed ID: 10698705
[TBL] [Abstract][Full Text] [Related]
8. Chiral recognition at the heme active site of nitric oxide synthase is markedly enhanced by L-arginine and 5,6,7,8-tetrahydrobiopterin.
Nakano K; Sagami I; Daff S; Shimizu T
Biochem Biophys Res Commun; 1998 Jul; 248(3):767-72. PubMed ID: 9704002
[TBL] [Abstract][Full Text] [Related]
9. Two modes of binding of N-hydroxyguanidines to NO synthases: first evidence for the formation of iron-N-hydroxyguanidine complexes and key role of tetrahydrobiopterin in determining the binding mode.
Lefèvre-Groboillot D; Frapart Y; Desbois A; Zimmermann JL; Boucher JL; Gorren AC; Mayer B; Stuehr DJ; Mansuy D
Biochemistry; 2003 Apr; 42(13):3858-67. PubMed ID: 12667076
[TBL] [Abstract][Full Text] [Related]
10. BYK191023 (2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3h-imidazo[4,5-b]pyridine) is an NADPH- and time-dependent irreversible inhibitor of inducible nitric-oxide synthase.
Tiso M; Strub A; Hesslinger C; Kenney CT; Boer R; Stuehr DJ
Mol Pharmacol; 2008 Apr; 73(4):1244-53. PubMed ID: 18178668
[TBL] [Abstract][Full Text] [Related]
11. Tetrahydrobiopterin-free neuronal nitric oxide synthase: evidence for two identical highly anticooperative pteridine binding sites.
Gorren AC; List BM; Schrammel A; Pitters E; Hemmens B; Werner ER; Schmidt K; Mayer B
Biochemistry; 1996 Dec; 35(51):16735-45. PubMed ID: 8988010
[TBL] [Abstract][Full Text] [Related]
12. The inhibition of the constitutive bovine endothelial nitric oxide synthase by imidazole and indazole agents.
Wolff DJ; Lubeskie A; Umansky S
Arch Biochem Biophys; 1994 Nov; 314(2):360-6. PubMed ID: 7526799
[TBL] [Abstract][Full Text] [Related]
13. The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes.
Boer R; Ulrich WR; Klein T; Mirau B; Haas S; Baur I
Mol Pharmacol; 2000 Nov; 58(5):1026-34. PubMed ID: 11040050
[TBL] [Abstract][Full Text] [Related]
14. Redox function of tetrahydrobiopterin and effect of L-arginine on oxygen binding in endothelial nitric oxide synthase.
Berka V; Yeh HC; Gao D; Kiran F; Tsai AL
Biochemistry; 2004 Oct; 43(41):13137-48. PubMed ID: 15476407
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of nitric oxide synthase isoforms by porphyrins.
Wolff DJ; Naddelman RA; Lubeskie A; Saks DA
Arch Biochem Biophys; 1996 Sep; 333(1):27-34. PubMed ID: 8806750
[TBL] [Abstract][Full Text] [Related]
16. Cysteine 99 of endothelial nitric oxide synthase (NOS-III) is critical for tetrahydrobiopterin-dependent NOS-III stability and activity.
Chen PF; Tsai AL; Wu KK
Biochem Biophys Res Commun; 1995 Oct; 215(3):1119-29. PubMed ID: 7488039
[TBL] [Abstract][Full Text] [Related]
17. Cellular and enzymatic studies of N(omega)-propyl-l-arginine and S-ethyl-N-[4-(trifluoromethyl)phenyl]isothiourea as reversible, slowly dissociating inhibitors selective for the neuronal nitric oxide synthase isoform.
Cooper GR; Mialkowski K; Wolff DJ
Arch Biochem Biophys; 2000 Mar; 375(1):183-94. PubMed ID: 10683266
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of new sulfur-containing L-arginine-derived inhibitors of nitric oxide synthase.
Ichimori K; Stuehr DJ; Atkinson RN; King SB
J Med Chem; 1999 May; 42(10):1842-8. PubMed ID: 10346937
[TBL] [Abstract][Full Text] [Related]
19. Comparative functioning of dihydro- and tetrahydropterins in supporting electron transfer, catalysis, and subunit dimerization in inducible nitric oxide synthase.
Presta A; Siddhanta U; Wu C; Sennequier N; Huang L; Abu-Soud HM; Erzurum S; Stuehr DJ
Biochemistry; 1998 Jan; 37(1):298-310. PubMed ID: 9425051
[TBL] [Abstract][Full Text] [Related]
20. Analysis of substrate-induced electronic, catalytic, and structural changes in inducible NO synthase.
Sennequier N; Stuehr DJ
Biochemistry; 1996 May; 35(18):5883-92. PubMed ID: 8639550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
